Detalles de la búsqueda
1.
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
Proc Natl Acad Sci U S A
; 106(38): 16281-6, 2009 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-19805294
2.
Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.
Sci Rep
; 8(1): 3965, 2018 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29487345
3.
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.
Sci Rep
; 7(1): 6689, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28751748
4.
Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.
Mol Oncol
; 10(2): 253-71, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26514616
5.
Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.
J Thorac Oncol
; 11(5): 718-728, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26804638
6.
Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.
Oncotarget
; 7(37): 58903-58914, 2016 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27385213
7.
Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
Cancer Res
; 75(17): 3636-49, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26141860
8.
Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.
J Thorac Oncol
; 7(4): 631-42, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22425911
Resultados
1 -
8
de 8
1
Próxima >
>>